Home Blog Page 1238

Kavalan Launches Limited Edition Dry Peated Whisky Highball in Japan

Award-winning smoky whisky meets refreshing sparkle this Christmas

TAIPEI, Dec. 16, 2025 /PRNewswire/ — Kavalan is ushering in the festive season with its first-ever Ready-to-Drink (RTD) Dry Peated Whisky Highball, a limited-edition release crafted exclusively for Japan and available only at Lawson stores nationwide.

Smoky elegance meets refreshing balance as Kavalan launches its first Dry Peated Whisky Highball exclusively for Japan.
Smoky elegance meets refreshing balance as Kavalan launches its first Dry Peated Whisky Highball exclusively for Japan.

Marrying smoky sophistication with crisp refreshment, it brings Kavalan’s signature elegance into Japan’s beloved highball culture.

Using its award-winning Peated Whisky, crowned “Best of the Best” Single Malt Whisky at the 2024 Tokyo Whisky & Spirits Competition (TWSC), Kavalan has created a drink that balances peaty depth with tropical vibrancy.

King Car Group Chairman and Kavalan CEO Mr. Yu-Ting Lee said the new release captures the festive spirit in every sip.

“Whether enjoyed at an izakaya or an outdoor gathering, this limited-edition highball celebrates Japan’s highball tradition while appealing to whisky and cocktail lovers worldwide,” he said. “We’ve used our premium 50–59.9% ABV peated whisky as the base to achieve a perfect harmony of smokiness and fruit-forward notes.”

The Kavalan Bar Cocktail Dry Peated Whisky Highball (320ml, 7% ABV) combines peated whisky with crisp soda water, delivering a refreshing, layered experience with zero added sugar. It will be available nationwide at Lawson stores from mid-December, with a suggested retail price of JPY 528 (tax included).

Embodying the theme “smoky elegance meets refreshing balance,” the design features a deep purple and champagne gold palette, symbolising the fusion of rich smokiness and tropical brightness while reflecting Kavalan’s refined, modern Taiwanese style.


Kavalan Bar Cocktail Dry Peated Whisky Highball

Volume / ABV / Price: 320 ml / 7% ABV / JPY 528 (tax included)
Launch Date: Tuesday, 16 December 2025
Availability: Lawson exclusive, available nationwide in Japan
Excludes Lawson Store 100, non-alcohol Lawson stores, and select locations.

 

About Kavalan Whisky

Kavalan Distillery in Yilan County has been pioneering the art of single malt whisky in Taiwan since 2005. Our whisky, aged in intense humidity and heat, sources the crystal meltwaters of Snow Mountain and is enhanced by sea and mountain breezes. These conditions combine to create Kavalan’s signature creaminess. Taking Yilan County’s old name, our distillery is backed by more than 45 years of beverage-making under parent company, King Car Group. We have collected 950 gold or higher awards from the industry’s most competitive contests.

About Nihon Shurui Hanbai Co., Ltd.

Founded in 1949, Nihon Shurui Hanbai Co., Ltd. is a Japanese wholesaler specialising in food and alcoholic beverages. As its name suggests, the company is particularly renowned for its strong and extensive network within the liquor industry.

Its business activities include the domestic and international trading, importing, and exporting of alcoholic beverages, soft drinks, other beverages, food products, and related raw materials.

CONTACT: 
Kaitlyn Tsai
kaitlyn@kingcar.com.tw 

Chandler Good Government Index 2025: Asia’s Top Governments Revealed

HA NOI, Viet Nam, Dec. 16, 2025 /PRNewswire/ — The 2025 Chandler Good Government Index (CGGI) shows that sustained investment in core capabilities is driving governance gains across Asia Pacific, even as global “governance competition” intensifies. These findings were highlighted yesterday at a regional knowledge-sharing forum in Ha Noi, hosted by the Ho Chi Minh National Academy of Politics (HCMA), the Academy of Public Administration and Governance (APAG) and the Chandler Institute of Governance (CIG).

Experience the full interactive Multichannel News Release here: https://www.multivu.com/chandler-institute-of-governance/9372451-en-chandler-good-government-index-2025

Now in its fifth year, the CGGI measures government capabilities and outcomes in 120 countries. It benchmarks national performance across seven pillars: Leadership and Foresight, Robust Laws and Policies, Strong Institutions, Financial Stewardship, Attractive Marketplace, Global Influence and Reputation, and Helping People Rise.

Speaking at the forum, Dinesh Naidu, Director (Knowledge) at CIG, noted the region’s diversity and resilience. “The countries that continue to advance are those that invest in long-term capabilities – building strong institutions, strengthening regulatory systems, and planning for the future. Asia offers many examples of how governments can make steady, practical improvements even in a complex global environment.”

Watch the Forum Recording: https://bit.ly/4pDMwcX
Download the Presentation Here 

Viet Nam: a notable improver in Asia

Viet Nam has emerged as one of the region’s most significant improvers since the CGGI’s inaugural edition in 2021. It has risen 12 places over five years, from 60th in 2021 to 48th in 2025. It has strengthened six of the seven CGGI pillars, with notable gains in Leadership and Foresight (up 31 places) and Financial Stewardship (up 20 places). Viet Nam now ranks 30th globally for Leadership and Foresight, supported by improvements in strategic prioritisation and long-term vision.

These gains reflect momentum in Viet Nam‘s public sector reform, including efforts to streamline administrative structures and modernise service delivery. These reforms align with the country’s goal of becoming a high-income nation by 2045.

Asia Pacific: diverse trajectories with strong performers

Asia Pacific remains one of the most diverse governance regions in the Index. In the 2025, Singapore (1), Australia (12), New Zealand (13), South Korea (17), and Japan (19) form the region’s top five performers. Their consistent performance over multiple editions underscores the value of long-term institutional investment. Singapore continues to demonstrate strengths in Leadership and Foresight, Strong Institutions, and Attractive Marketplace. New Zealand remains a global reference point for fiscal responsibility and public trust, while Japan maintains stability through strong regulatory quality and data capability.

Among emerging economies, Mongolia has risen 12 places, from 88th in 2021 to 76th in 2025, with gains in Leadership and Foresight, Financial Stewardship and Attractive Marketplace, supported by its Vision 2050 strategy and advances in digital service delivery. Indonesia has also strengthened national planning systems and regulatory governance, with improvements since 2021 in indicators related to strategic prioritisation, long-term vision, and administrative efficiency.

These developments reflect a broader global trend: governments that invest in capability see tangible progress relative to their peers. This dynamic is part of what the Index refers to as “governance competition”, where advances in one country raise expectations for others. “The CGGI shows that capability building matters. As countries improve faster, they raise the bar and set new benchmarks for everyone else. Standing still is no longer an option,” Naidu said.

A practical tool for governments

Designed by practitioners for practitioners, the CGGI offers governments practical benchmarks and insights to support long-term capability development. Countries use the Index to understand their strengths, identify areas for improvement, and learn from peers across the region.

“The Index is intended to support governments that are committed to long-term improvement,” Naidu added. “We hope today’s discussions contribute to a stronger, more capable, and future-ready Asia Pacific.”

The Chandler Institute of Governance (CIG) is a non-profit organisation that works with governments worldwide to build a strong and efficient public sector. We focus on the critical ‘how’ of governance in our partnerships with governments to strengthen institutions and systems, equip leaders, and share knowledge. We are not affiliated with any national government or political party, and we do not represent any partisan or commercial interests.

Azazie Introduces the Elevated Little White Dress – A Modern Bride’s Go-To for Engagement Season and Beyond

LOS ANGELES, Dec. 16, 2025 /PRNewswire/ — Just in time for engagement season, Azazie introduces its Elevated Little White Dress collection—a fashion-forward edit of modern bridal styles designed for every celebration leading up to “I do.” Thoughtfully crafted with elevated fabrics, couture-inspired details, and flattering silhouettes, each dress in the collection is priced under $250, making luxury bridal style more accessible than ever.

From surprise proposals and engagement parties to bridal showers, rehearsal dinners, and bachelorette weekends, the Elevated LWD collection is a fresh take on modern bridal dressing. Think clean lines, flattering tailoring, and elevated details that feel fashion-forward yet timeless—perfect for brides who want to look unmistakably “bridal” without feeling overdone.

Each piece in the collection is thoughtfully designed to strike the balance between sophistication and ease. Delicate draping, subtle structure, luxe fabrics, and playful hemlines make these dresses ideal for both intimate celebrations and statement-making moments. Whether you’re saying “yes” at a candlelit dinner or toasting with friends at a rooftop soirée, these little white dresses are designed to move with you, whatever the moment calls for —and photograph beautifully while doing so.

Azazie
Azazie

True to Azazie’s commitment to accessibility, the Elevated LWD collection combines high-style design with approachable price points and inclusive sizing from 0–30, ensuring every bride can find a look that feels uniquely her. Designed to be worn well beyond the aisle-adjacent moments, these little white dresses transition effortlessly from engagement celebrations to future special occasions—proof that bridal style can be just as versatile as it is unforgettable.

As engagement season unfolds, Azazie’s Elevated Little White Dresses offer a modern wardrobe solution for brides who want to celebrate every milestone in style—confident, polished, and unmistakably themselves.

The Elevated Little White Dress collection is available now at Azazie.com.

Perennial Healthcare City Launched Adjacent to Chongqing East HSR Station, Western China’s Largest HSR Hub

  • Establishment of new healthcare gateway in Chongqing amid the 10th anniversary of the Chongqing Connectivity Initiative and as part of the 35th anniversary celebration of SingaporeChina diplomatic relations;
  • Maiden investment in Chongqing marks Perennial Holdings’ sixth healthcare-centric TOD, further strengthening its footprint in China 

SINGAPORE, Dec. 16, 2025 /PRNewswire/ — Perennial Holdings Private Limited (“Perennial Holdings“) yesterday launched Perennial Healthcare City, adjacent to the Chongqing East High-Speed Railway (“HSR“) Station (“Perennial Healthcare City Chongqing“). Perennial Healthcare City Chongqing, which is majority owned and led by Perennial Holdings, is jointly developed with Chongqing Transportation Development and Investment Group Co., Ltd (“Chongqing Transportation and Investment Group“) and China Railway Construction Group Co., Ltd (“China Railway Construction Group“). Chongqing East HSR station is the largest and only national-level HSR hub in Western China.

The first phase of Perennial Healthcare City Chongqing, spanning approximately 140,000 square meters (“sqm“) and to be developed at a total investment cost of approximately RMB1.5 billion, will comprise a 500-bed Perennial General Hospital, a tertiary general hospital, and several specialist hospitals. This first phase is expected to progressively complete from 2028. Subsequent phases, measuring over 260,000 sqm, are expected to comprise eldercare, serviced residences, hospitality and commercial components, when executed.

The launch ceremony, which was held amid the 10th anniversary of the ChinaSingapore (Chongqing) Demonstration Initiative on Strategic Connectivity (“Chongqing Connectivity Initiative“) and as part of the 35th anniversary celebration of diplomatic relations between Singapore and China, was graced by Guests-of-Honour, Mr Gan Kim Yong, Singapore Deputy Prime Minister and Minister for Trade and Industry, Mrs Josephine Teo, Singapore Minister for Digital Development and Information and Minister-in-charge of Cybersecurity & Smart Nation Group, Dr Tan See Leng, Singapore Minister for Manpower and Minister-in-charge of Energy and Science & Technology in the Ministry of Trade and Industry, Mr Tan Kiat How, Singapore Senior Minister of State for Ministry of Digital Development and Information & Ministry of Health, and Mr Peter Tan, Singapore’s Ambassador to the People’s Republic of China. Special guests also included government officials of the Chongqing Municipal Government, Chongqing Foreign Affairs Office, Chongqing Municipal Commission of Commerce, Chongqing Connectivity Initiative Administration Bureau, Nan’an District and Jingkai District Economic Development Zone, Mr Shi Jidong, Party Secretary and Chairman of Chongqing Transportation and Investment Group, Mr Zhao Xiangdong, General Manager and Deputy Party Secretary of China Railway Construction Group, as well as bankers, business partners and the media.

Perennial Healthcare City Chongqing Phase 1 - Overview 1
Perennial Healthcare City Chongqing Phase 1 – Overview 1

Perennial Healthcare City Chongqing Phase 1 - Overview 2
Perennial Healthcare City Chongqing Phase 1 – Overview 2

Perennial Healthcare City Chongqing Phase 1 - Overview 3
Perennial Healthcare City Chongqing Phase 1 – Overview 3

From left to right: Mr Zhao Xiangdong, General Manager and Deputy Party Secretary of China Railway Construction Group; Mr Pua Seck Guan, Executive Chairman and Chief Executive Officer, Perennial Holdings; Mr Gan Kim Yong, Singapore Deputy Prime Minister and Minister for Trade and Industry; Mr Shi Jidong, Party Secretary and Chairman of Chongqing Transportation and Investment Group
From left to right: Mr Zhao Xiangdong, General Manager and Deputy Party Secretary of China Railway Construction Group; Mr Pua Seck Guan, Executive Chairman and Chief Executive Officer, Perennial Holdings; Mr Gan Kim Yong, Singapore Deputy Prime Minister and Minister for Trade and Industry; Mr Shi Jidong, Party Secretary and Chairman of Chongqing Transportation and Investment Group

From left to right: Mr Zhao Xiangdong, General Manager and Deputy Party Secretary of China Railway Construction Group; Mr Tan Kiat How, Singapore Senior Minister of State for Ministry of Digital Development and Information & Ministry of Health; Mrs Josephine Teo, Singapore Minister for Digital Development and Information and Minister-in-charge of Cybersecurity & Smart Nation Group; Mr Pua Seck Guan, Executive Chairman and Chief Executive Officer, Perennial Holdings; Mr Gan Kim Yong, Singapore De
From left to right: Mr Zhao Xiangdong, General Manager and Deputy Party Secretary of China Railway Construction Group; Mr Tan Kiat How, Singapore Senior Minister of State for Ministry of Digital Development and Information & Ministry of Health; Mrs Josephine Teo, Singapore Minister for Digital Development and Information and Minister-in-charge of Cybersecurity & Smart Nation Group; Mr Pua Seck Guan, Executive Chairman and Chief Executive Officer, Perennial Holdings; Mr Gan Kim Yong, Singapore De

Perennial Healthcare City Chongqing will inject fresh momentum into the growth of the healthcare industry in Chongqing, a national central city with a total population of over 32 million, and the Western China region, which has a total population of over 360 million people.

Chongqing East HSR Station, a key intersection of five major corridors under China’s ‘Eight Vertical and Eight Horizontal’ HSR plan, further elevates the strategic significance of Chongqing and the expansive reach of Perennial Healthcare City Chongqing. The station connects to seven HSR lines, two regular railway lines and four planned metro lines, and features 15 platforms and 29 arrival and departure tracks. This bustling transport hub is designed to handle an annual passenger volume of 55 million and will improve connectivity to the Western inland areas, the Eastern coastal region and the Pan-Asian HSR network to ASEAN. Domestic travellers will benefit from reduced transport times, reaching Chengdu, Qianjiang, Wanzhou and Guiyang within an hour, and Xi’an, Wuhan, Changsha and Kunming within three hours.

Mr Pua Seck Guan, Executive Chairman and Chief Executive Officer of Perennial Holdings, said, “We are honoured to mark our maiden investment in Chongqing through the introduction of our signature healthcare-centric, integrated transit-oriented development (“TOD“). The establishment of Perennial Healthcare City Chongqing, strategically located adjacent to the largest and national-level HSR station in the country, is a fruition of the strong relationship between the governments of Singapore and Chongqing.”

Mr Pua, added, “By harnessing Singapore’s international healthcare standards alongside Chongqing’s high-quality medical resources, we aim to deliver exceptional medical services to the community and expatriates from multinational companies establishing regional headquarters in the city as part of the Chongqing Connectivity Initiative, through leveraging the excellent connectivity of Chongqing East HSR Station, positioning Perennial Healthcare City Chongqing as the definitive healthcare destination for Western China and beyond.”

Mr Shi Jidong, Party Secretary and Chairman of Chongqing Transportation and Investment Group, said, “Perennial Healthcare City Chongqing marks another landmark achievement of the Chongqing Connectivity Initiative, and is also the first premier healthcare development within the vicinity of the Chongqing East HSR Station. This development will bring international, high-quality medical and healthcare resources to the Chongqing East HSR Station zone, elevating services available to the community across the region.”

Mr Gan Kim Yong, Singapore Deputy Prime Minister and Minister for Trade and Industry, said, “Congratulations to Perennial Holdings on this significant milestone. Located near Chongqing East HSR station, Perennial Healthcare City Chongqing integrates healthcare, commercial and community facilities with a major transport hub, supporting Chongqing’s development as a regional medical centre. As we mark the 10th anniversary of the Chongqing Connectivity Initiative this year, Singapore will continue to deepen our collaboration with Chongqing, including in newer sectors such as healthcare, for the benefit of our peoples.”

Perennial Holdings focuses on healthcare-centric large-scale TODs integrating medical care, eldercare and hospitality components. Together with Perennial Healthcare City Chongqing, Perennial Holdings has six healthcare-centric TODs in China connected to HSR stations, including Tianjin, Chengdu, Kunming, Xi’an and Guangzhou.

For media enquiries, please contact:

 

Ms Tong Ka-Pin

Chief Corporate Officer

DID: (65) 6602 6828

HP: (65) 9862 2435

Email: tong.ka-pin@perennialholdings.com

 

 

Ms Crystal Tan

Assistant Manager, Investor Relations, Corporate

Communications & Marketing

DID: (65) 6602 0994

HP: (65) 8128 8268

Email: crystal.tan@perennialholdings.com

 

About Perennial Holdings Private Limited (www.perennialholdings.com) 

Perennial Holdings Private Limited (“Perennial Holdings“) is an established integrated healthcare and real estate company headquartered in Singapore. The Company owns, manages and operates over 28,000 beds in medical and eldercare facilities, comprising about 17,000 operational beds and over 11,000 beds in the pipeline, across 16 cities in China and Singapore. In China, Perennial Holdings owns and operates the country’s first private integrated healthcare ecosystem, which combines a unique medical platform centred on partnerships with doctors and one of the largest private eldercare platforms in the country. Its comprehensive medical care facilities encompass general, rehabilitation, specialist and nursing hospitals, while its eldercare facilities include independent living, assisted living, nursing homes and dementia care. In Singapore, the Company will operate Perennial Living, the nation’s first private assisted living development and is set to launch Perennial Wellness, the country’s first-of-its-kind private integrated rehabilitation and traditional Chinese medicine centre, at Perennial Living and Jervois Road.

Perennial Holdings’ quality real estate portfolio spans over 84 million square feet in total gross floor area across China, Singapore, Malaysia and Indonesia. The Company focuses strategically on large-scale transit-oriented developments (“TODs“), serving as enablers of its healthcare portfolio, and landmark integrated developments. It has seven TODs in China which are connected to high-speed railway (“HSR“) stations, of which six, located in Tianjin, Chengdu, Kunming, Xi’an, Guangzhou and Chongqing, are healthcare-centric, and one commercial-centric HSR TOD is in Hangzhou.

Titomic Secures Early Manufacturing Development Contract with Leading Defense Prime

HUNTSVILLE, Ala., Dec. 16, 2025 /PRNewswire/ — Titomic Limited (ASX: TTT), a global leader in cold spray additive manufacturing utilizing their Titomic Kinetic Fusion™ technology, is pleased to announce it has secured an Early Manufacturing Development (EMD) contract with a leading defense prime contractor to support a new effort for production of next-generation defense articles. The collaboration will establish and validate an innovative manufacturing approach intended to accelerate production, improve supply-chain resilience, and deliver critical components to the warfighter faster. The initial EMD contract is valued at USD 1,700,000 (AUD 2,550,000) and is expected to be fulfilled by mid-2026 with manufacturing to be undertaken in Titomic’s Huntsville facility.

Under the EMD contract, Titomic will work closely with the defense partner to develop manufacturing pathways that address long-standing production delays and capacity constraints across the defense industrial base. The effort leverages Titomic’s proprietary cold-spray additive manufacturing systems, known for their ability to rapidly build high-strength, near-net-shape metal parts with minimal waste. By compressing development timelines and enabling scalable production, Titomic’s technology is positioned to help defense programs transition quickly from concept to readiness then to serial production.

This new engagement reinforces Titomic’s growing role as a strategic supplier supporting defense modernization initiatives. Around the world, defense organizations and armed forces are seeking new approaches to overcome slow manufacturing cycles, fragile supply chains, and increasing demand for complex metal components. Titomic’s capabilities offer higher throughput, enhanced material performance, and the flexibility to produce parts that are difficult, time-consuming and/or costly to manufacture through traditional methods.

“Securing this Early Manufacturing Development contract marks another important milestone for Titomic as we continue to expand our impact throughout the defense sector,” said Dr. Patti Dare, President of Titomic, USA. “Our advanced manufacturing technology is designed to break through production bottlenecks and ensure critical assets and solutions reach the warfighter in a mission-relevant timeframe. We are proud to support this initiative and look forward to strengthening our partnership with this leading defense prime.”

This announcement has been authorized for release by Titomic’s Board of Directors.

Newmark Expands APAC Presence with Korea Launch, Appointing John Pritchard as Country Head

NEW YORK and SEOUL, South Korea, Dec. 16, 2025 /PRNewswire/ — Newmark Group, Inc. (Nasdaq: NMRK) (“Newmark”), a leading commercial real estate advisor and service provider to global corporations, institutional investors, and owners and occupiers, announces it has established its Korean flagship in Seoul, hiring a seasoned leadership team across multiple disciplines. The office, located in the IFC Complex in Yeouido, officially opens this month and will focus on all industry verticals and asset classes. The business will be led by John Pritchard serving as Managing Director and Country Head. Pritchard brings nearly two decades of experience, having advised global corporates on some of the Korean market’s largest occupier transactions.

Image courtesy of Nemwark: Front Row L to R: Judy Jang, John Pritchard, Karis Kim, Miji Kyung; Back Row L to R: Leadley Park, Chan Joung, Sienna Ahn.
Image courtesy of Nemwark: Front Row L to R: Judy Jang, John Pritchard, Karis Kim, Miji Kyung; Back Row L to R: Leadley Park, Chan Joung, Sienna Ahn.

“Our entry into Korea reflects Newmark’s continued evolution as a truly global firm,” said Barry Gosin, Chief Executive Officer of Newmark. “Korea is one of Asia’s most advanced and rapidly growing economies, defined by innovation and global influence. Establishing a presence here allows us to support corporations expanding internationally and deliver world-class advisory services to clients entering the market. This reinforces our long-term commitment to building a connected, future-focused platform that meets the evolving needs of global clients.”

Together with Pritchard, the launch of Newmark’s operations in Korea will include a dynamic team operating across key service disciplines. Collectively, the team arrives from leading multinational commercial real estate firms, contributing a broad spectrum of expertise across Korea’s most active sectors.

  • Karis Kim, Head of Retail, Tenant Representation: Karis has led flagship retail mandates for the world’s largest global brands across Korea, driving market-defining transactions and shaping the country’s modern retail landscape.
  • Judy Jang, Head of Research: With over two decades of experience, Judy is well known for best-practice research and for pioneering sector specific market reports. Prior to joining Newmark, she built research platforms at leading global commercial real estate firms.
  • Miji Kyung, Associate Director: Miji advises multinational clients on their Korean corporate real estate strategy. Miji is a leader for the multinational office tenant representation platform, working closely along side Pritchard.
  • Sienna Ahn,Senior Manager, Tenant Representation: Sienna specializes in market intelligence and leasing advisory across Seoul and Korea’s key secondary markets.
  • Leadley Park, Senior Manager, Tenant Representation: Leadley’s background includes retail and office advisory for global fast-fashion and F&B brands.
  • Chan Joung, Manager, Tenant Representation: Chan advises Korean corporations on overseas expansion strategies across office, logistics, and industrial assets.

“Newmark’s business in Korea embodies the next generation of real estate advisory – tech-enabled, insight-driven, and globally connected,” said John Pritchard, Managing Director and Country Head – Korea. “As the world’s 10th-largest economy and a global leader in sectors including technology, automotive, logistics, and finance, the country’s outward investment momentum and deep corporate sophistication make it a central gateway for international occupiers and investors. With an accomplished leadership team already in place, we are establishing a presence that connects Korea’s most innovative enterprises to opportunities worldwide.”

As one of the fastest-growing commercial real estate firms in the world, Newmark continues to invest in expanding its capabilities, infrastructure, and geographic footprint, building on its record of sustained growth and its commitment to excellence across service lines and geographies. The opening of Newmark’s Korea office follows recent expansions in Bangalore, Chennai, Dubai, Singapore, Munich and Paris.

About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries (“Newmark”), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark’s comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform’s global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. For the twelve months ended September 30, 2025, Newmark generated revenues of over $3.1 billion. As of September 30, 2025, Newmark and its business partners together operated from approximately 170 offices with over 8,500 professionals across four continents. To learn more, visit nmrk.com or follow @newmark.

Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are “forward-looking statements” that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company’s business, results, financial position, liquidity, and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark’s Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.

Newmark Group, Inc.
Newmark Group, Inc.

 

Enginprime Medical Inc Announces First-in-Human Study of Its Leading OpusOne™ pVAD

HANGZHOU, China, Dec. 16, 2025 /PRNewswire/ — Enginprime Medical Inc (“Enginprime”), an emerging leader in percutaneous ventricular assist device (pVAD) technologies and a Voyagers Capital portfolio company, today announced that its industry leading pVAD, OpusOne™, has entered its first-in-human clinical study at The Second Affiliated Hospital, School of Medicine, Zhejiang University (“SAHZU”). This milestone marks the first clinical evaluation of the device’s safety and performance in patients.

PVAD supports the cardiac output via a percutaneously implanted pump, reduces the load of left ventricle, relieves heart failure symptoms, and bridges to transplantation or recovery. It also delivers temporary hemodynamic support during Complex Higher-risk Indicated Patients Percutaneous Coronary Intervention (CHIP PCI) procedures by augmenting cardiac output, preserving organ perfusion, and stabilizing hemodynamics for safe intervention. While over 60,000 pVAD procedures are performed globally each year, no pVAD product has been approved in China yet, underscoring the significant unmet medical need.  

OpusOne™ features an ultra-low profile down to 8F, external durable motor placement, and an all-new design of foldable, self-expanding impeller, capable of delivering 4–5 L/min of average flow with peak flows exceeding 7 L/min. Notably, this ultra-compact device integrates invasive blood pressure monitoring and patented perfusion purification system, enabling migration detection alerts while preventing wear particles from entering the patient’s body. With high durability, enhanced reliability, OpusOne™ simplifies clinical procedures, improves patient accessibility, and emerges as a highly competitive pVAD – rivaling Abiomed’s Impella, Magenta’s Elevate, and Supira’s pVAD systems.

First-in-Human Study of OpusOne™ pVAD at SAHZU”
First-in-Human Study of OpusOne™ pVAD at SAHZU”

“Enginprime’s OpusOneTM exemplified a promising approach to temporary ventricular support—especially for high-risk patients who can benefit from enhanced hemodynamic stability. Co-developed by the interventional cardiologists and Enginprime, this promising solution is tailored to address unmet clinical needs.” said the study’s lead investigator Jian’an Wang, MD,PhD, Director of the Cardiac Center at SAHZU. “I am impressed by its ability to achieve high flow with such a low-profile design. OpusOneTM‘s optimization of access and positioning options increases procedural safety.”

Co-investigator of the study, Jun Jiang, MD, PhD, Executive Associate Director of the Department of Cardiology at SAHZU added, “We are pleased to perform the first procedure with OpusOneTM, seeing the patient’s chest tightness was significantly alleviated. Its robust initial performance marks a meaningful advancement in circulatory support and great potential for expanding patient eligibility.”

“The development of OpusOneTM reflects our mission to bring globally competitive, exceptional performance and high reliability, cost-effective next-generation circulatory support products to patients who need them most,” said the CEO of Enginprime. “We look forward to advancing this innovative device rapidly through further clinical validations.”

About Enginprime Medical Inc.

Enginprime was established in 2023 and incubated under majority ownership by Voyagers Capital, leveraging cross-disciplinary engineering capabilities, systems integration expertise, and advanced manufacturing methodologies. OpusOne™ is the company’s first flagship medical device platform and reflects Voyagers’ long-term commitment to supporting breakthrough healthcare technologies.

About Voyagers Capital

Voyagers Capital is a leading healthcare venture capital firm focused on investing in groundbreaking biotech and medtech innovation. By leveraging our expertise and network, we partner with visionary entrepreneurs to bring transformative solutions to the global market.

OpusOne™ is an investigational device, not yet approved for commercial use.

For more information, please contact:
media@enginprime.com; info@voyagerscap.com.

 

Miroma Project Factory: Powers Clinical-Grade App for One of Australia’s Largest Smoking Cessation Trials

SYDNEY, Dec. 16, 2025 /PRNewswire/ — Miroma Project Factory (MPF) has delivered a bespoke mobile solution for Screen2Quit, part of the International Lung Study trial and one of Australia’s most ambitious research studies targeting smoking cessation in people undergoing lung cancer screening.

Screen2Quit by Miroma Project Factory: powering Australia’s largest smoking cessation trial with clinical-grade app technology.
Screen2Quit by Miroma Project Factory: powering Australia’s largest smoking cessation trial with clinical-grade app technology.

Commissioned by the Thoracic Research Centre at the University of Queensland and developed in partnership with Queensland Health, Screen2Quit is a revised, clinical version of the My QuitBuddy application redeveloped and instrumented to collect participant backend data for a multi-year randomised controlled trial (RCT). The goal: to determine whether app-based interventions can significantly outperform websites or control conditions in helping people quit smoking, still the leading cause of preventable disease worldwide.

From the outside, Screen2Quit looks and feels familiar to a smoking cessation application, but beneath the surface lies a purpose-built digital trial engine capable of tracking every interaction, from user-entered quit plans through scrolling and page navigation to community engagement, all while maintaining strict research integrity.

MPF’s scope included native app development for both iOS and Android, and the creation of two secure backends. One backend supports community forum moderation, while the bespoke administration portal captures trial-specific analytics and fully anonymised data capture. Each app user is registered via a unique trial ID that gates access and ties in-session behaviour to anonymised clinical outcomes, enabling researchers to explore how digital behaviours relate to real-world smoking cessation.

“We’re proud to help deliver a real-world health intervention that’s not only scalable, but scientifically robust,” said Jennifer Wilson, Founder and Futurist MPF. “Screen2Quit takes behaviour change out of the lab and into people’s lives—with real data to back it.”

The build was delivered in two structured phases:

  • Phase 1 focused on core functionality: onboarding updates for trial enrollment, user navigation improvements, analytics configuration, regional localisation, and the creation of a trial-specific forum with moderator tools.
  • Phase 2 added deeper analytics, forum download features, enhanced user activity logging, and infrastructure support for multi-jurisdiction deployment.

The app is deployed as part of the ILST (International Lung Screen Trial), which is funded by the NHMRC and supported by a cross-disciplinary clinical team. MPF continues to support the platform under a multi-year maintenance agreement, providing technical oversight, app store management, and hosting infrastructure for the duration of the trial.

About Screen2Quit (MQB UniQLD)

Screen2Quit is a clinical trial app developed for the International Lung Screen Trial, a multi-jurisdiction randomised controlled study coordinated by the University of Queensland Thoracic Research Centre. Based on the evidence-based My QuitBuddy app, Screen2Quit was redeveloped for use in clinical research, enabling detailed tracking of user behaviour and its relationship to smoking cessation outcomes. The app is only available to enrolled trial participants.

About Miroma Project Factory (MPF)

MPF is a multi-award-winning digital strategy and product studio that delivers innovative digital solutions across app, web, platforms, and systems. Specialising in purposeful technology, MPF works at the intersection of strategy, design, and engineering to create impactful digital products for organisations ready to lead. With deep expertise in healthcare, MPF helps clients scale responsibly, communicate clearly, and connect meaningfully with their audiences. For more information, visit www.theprojectfactory.com.

For media enquiries, interviews or partnership opportunities, please contact:
Miroma Project Factory
info@theprojectfactory.com

Henry Marshall
Thoracic Research Centre The University of Queensland
quit.research@health.qld.gov.au


Screen2Quit by Miroma Project Factory: powering Australia’s largest smoking cessation trial with clinical-grade app technology.
Screen2Quit by Miroma Project Factory: powering Australia’s largest smoking cessation trial with clinical-grade app technology.